Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 3 (a) Effects on perfusion of adenovirus-encoding vascular endothelial growth factor gene (Ad.VEGF) or adenovirus-encoding angiopoietin-1 gene (Ad.Ang-1) injection in normal nonischemic ears; Ad.Ang-1 does not increase perfusion, while VEGF transiently increases flow, compatible with an inflammatory response. (b) The Ang-1-mediated increase in flow in ischemic ears is abolished when Ad.Ang-1 is injected concomitantly with adenovirus-encoding soluble VEGF receptor gene [Ad.Flt(1-3)-Fc], which encodes a soluble VEGF receptor that binds to and abolishes VEGF signaling. Ad.Null = control adenovirus without transgene insert.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement